BeStock  
Stocks › Biotechnology › IDYA

IDEAYA Biosciences IDYA

US equityMarket cap rank #2556Biotechnology
$25.56 −$0.61 (-2.33%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $25.56 0.00%
Open$25.83
Prev close$26.17
Day range$25.46 – $26.87
Volume1.11M
Market cap$2.47B
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership107.1%-0.74 pts vs. prior quarter
Institutions holding351+1 vs. prior quarter
Insider trades (recent)42 buys / 6 sellsNet buying
Short interest8.54% of floatDays to cover 8.9 · as of 30 Oct 2026
Short-sale volume share22.0%5-day average of daily volume

Short-sale volume as % of daily volume

11%22%33%44%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$19.03M (6 inflow days, 14 outflow days).

Net flow by order size, last 20 sessions

−$18.5MSuper−$560.0KBig−$6.1MMid−$3.0MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 44.4% of shares outstanding.

Largest holders

  • FMR14.96%
  • BlackRock9.87%
  • Janus Henderson Group plc8.87%
  • Capital Research5.52%
  • Baker Bros. Advisors LP5.18%
  • Vanguard Capital Management, LLC4.46%
  • State Street Global Advisors4.06%
  • Logos Global Management, L.P.3.10%

By investor type

  • Mutual Fund78.72%
  • Hedge Fund19.60%
  • Public Company4.20%
  • VC/PE Fund2.41%
  • Government Pension Fund0.88%
  • Individual/Insider0.88%
  • Insurance Company0.55%
  • Private Company0.39%

Reported short interest has fallen from 10.78% to 8.54% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
BlackRock Mutual Fund 2026/Q3 +655,274 9.9%
FMR Mutual Fund 2026/Q3 +363,303 15.0%
J.P. Morgan Asset Management, Inc. Mutual Fund 2026/Q3 +211,628 0.4%
Vanguard Capital Management, LLC Mutual Fund 2026/Q3 +179,060 4.5%
Nuveen Asset Management LLC Insurance Company 2026/Q3 +224,281 0.5%
AllianceBernstein Mutual Fund 2026/Q3 +1,526,735 1.7%
Janus Henderson Group plc Mutual Fund 2026/Q3 +1,314,628 8.9%
Deerfield Management Company, L.P. Hedge Fund 2026/Q3 +1,184,495 2.8%
Baker Bros. Advisors LP Hedge Fund 2026/Q3 +1,063,515 5.2%
FMR Mutual Fund 2026/Q3 +932,945 14.6%
Arrowstreet Capital, Limited Partnership Mutual Fund 2026/Q3 +891,608 0.9%
T. Rowe Price Group, Inc. Mutual Fund 2026/Q3 +891,582 2.3%
State Street Global Advisors Mutual Fund 2026/Q3 +767,744 4.7%
Sio Capital Management, LLC Hedge Fund 2026/Q3 +480,383 0.5%
Vanguard Capital Management, LLC Mutual Fund 2026/Q3 +459,686 4.9%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
5 Oct 2026 Yujiro Hata Chairperson & CEO Derivative Exercise and Sale -26,338 $38.26 690,695
6 Jul 2026 Andres Briseno Chief Accounting Officer Derivative Exercise and Sale -9,550 $40.01 26,466
15 Jun 2026 Wendy Yarno Independent Director Other Derivative Acquisition +20,000 $30.57 20,000
15 Jun 2026 Jeffrey Stein Independent Director Other Derivative Acquisition +20,000 $30.57 20,000
15 Jun 2026 Scott William Morrison Independent Director Other Derivative Acquisition +20,000 $30.57 20,000
15 Jun 2026 Catherine Mackey Independent Director Other Derivative Acquisition +20,000 $30.57 20,000
15 Jun 2026 Terry Rosen Lead Independent Director Other Derivative Acquisition +20,000 $30.57 20,000
15 Jun 2026 Malcolm Hampton Independent Director Other Derivative Acquisition +20,000 $30.57 20,000
1 Mar 2026 Jeffrey Stein Independent Director Open Market Acquisition +50,000 $32.96 61,007
29 Jan 2026 Yujiro Hata Chairperson & CEO Other Derivative Acquisition +600,000 $32.19 600,000
29 Jan 2026 Douglas Snyder Chief Legal Officer Other Derivative Acquisition +130,000 $32.19 130,000
29 Jan 2026 Darrin Beaupre Chief Medical Officer Other Derivative Acquisition +175,000 $32.19 175,000
29 Jan 2026 Andres Briseno Chief Accounting Officer Other Derivative Acquisition +80,000 $32.19 80,000
29 Jan 2026 Michael White President of Research & Development Other Derivative Acquisition +190,000 $32.19 190,000
29 Jan 2026 Stuart Dorman Chief Commercial Officer Other Derivative Acquisition +155,000 $32.19 155,000
29 Jan 2026 Joshua Bleharski Chief Financial Officer Other Derivative Acquisition +170,000 $32.19 170,000
27 Nov 2025 Douglas Snyder Chief Legal Officer Other Acquisition +2,080 $16.91 2,080
27 Nov 2025 Andres Briseno Chief Accounting Officer Other Acquisition +1,935 $23.26 26,466
26 Jun 2025 Joshua Bleharski Chief Financial Officer Initial Statement of Beneficial +0 – 250,000
23 Jun 2025 Wendy Yarno Independent Director Other Derivative Acquisition +20,000 $21.78 20,000

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 8,236,480 8.5% 8.9
15 Oct 2026 9,079,434 9.4% 12.0
30 Sep 2026 9,183,217 9.5% 8.4
15 Sep 2026 9,931,622 10.3% 17.3
31 Aug 2026 10,103,757 10.5% 12.2
14 Aug 2026 10,398,078 10.8% 16.5

Discussion

No comments yet — be the first to weigh in on IDYA.

Sign in to join the discussion.

Scroll to Top